Skip to content
Abivax
EN
FR
About Abivax
Our Mission
Company History
Our Leadership
Contact Us
Our Science
Novel MOA
Obefazimod
Our Research
Our Pipeline
Publications
Investors
Overview
Press Releases
News
Share Price
Investor Documents
General Meeting
Corporate Presentation
EN
FR
News & Events
Press Coverage
2023
2022
2021
2020
2019
The Bio Report
November 26, 2020
Podcast with CEO Hartmut Ehrlich: Modulating RNA to Quell Disease
Capital Santé
November 13, 2020
Abivax Chairman Philippe Pouletty on the panel at Capital Santé
Pharmaceutiques
November 9, 2020
La pierre angulaire du développement des biotech
Evaluate Vantage
November 4, 2020
Scanning the horizon for future Covid-19 treatments
WANSQUARE
November 3, 2020
Abivax, la biotech qui s’apprête à devenir licorne
1
2
3
4
…
25
